| A synthetic adjuvant to enhance and expand immune responses to influenza vaccines RN Coler, SL Baldwin, N Shaverdian, S Bertholet, SJ Reed, VS Raman, ... PloS one 5 (10), e13677, 2010 | 171 | 2010 |
| From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH‐F3+ GLA‐SE RN Coler, MS Duthie, KA Hofmeyer, J Guderian, L Jayashankar, ... Clinical & translational immunology 4 (4), e35, 2015 | 154 | 2015 |
| Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL‐18, and IFN‐γ AL Desbien, SJ Reed, HR Bailor, ND Cauwelaert, JD Laurance, MT Orr, ... European journal of immunology 45 (2), 407-417, 2015 | 91 | 2015 |
| Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis MS Duthie, M Favila, KA Hofmeyer, YL Tutterrow, SJ Reed, JD Laurance, ... Vaccine 34 (25), 2779-2786, 2016 | 49 | 2016 |
| IL-18 and subcapsular lymph node macrophages are essential for enhanced B cell responses with TLR4 agonist adjuvants AL Desbien, N Dubois Cauwelaert, SJ Reed, HR Bailor, H Liang, D Carter, ... The Journal of Immunology 197 (11), 4351-4359, 2016 | 44 | 2016 |
| Trogocytosis-mediated intracellular signaling in CD4+ T cells drives TH2-associated effector cytokine production and differentiation J Reed, SA Wetzel The Journal of Immunology 202 (10), 2873-2887, 2019 | 39 | 2019 |
| Lymphocytes and trogocytosis-mediated signaling J Reed, M Reichelt, SA Wetzel Cells 10 (6), 1478, 2021 | 34 | 2021 |
| A defined subunit vaccine that protects against vector-borne visceral leishmaniasis MS Duthie, L Pereira, M Favila, KA Hofmeyer, SJ Reed, S Metangmo, ... NPJ vaccines 2 (1), 23, 2017 | 31 | 2017 |
| Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses AL Desbien, N Van Hoeven, SJ Reed, AC Casey, JD Laurance, ... Biotechniques 54 (6), 345-348, 2013 | 24 | 2013 |
| CD4+ T Cell Differentiation and Activation J Reed, SA Wetzel Immunotoxicity Testing: Methods and Protocols, 335-351, 2018 | 9 | 2018 |
| Solid tumor microenvironment can harbor and support functional properties of memory T cells PM Sullivan, SJ Reed, V Kalia, S Sarkar Frontiers in Immunology 12, 706150, 2021 | 6 | 2021 |
| Induction of thymic atrophy and loss of thymic output by type-I interferons during chronic viral infection T Démoulins, ML Baron, D Gauchat, N Kettaf, SJ Reed, T Charpentier, ... Virology 567, 77-86, 2022 | 5 | 2022 |
| Impacts of Trogocytosis-mediated Intracellular Signaling on CD4+ T Cell Effector Cytokine Production and Differentiation SJJ Reed University of Montana, 2019 | 1 | 2019 |
| Trogocytosis-Mediated Signaling Drives GATA-3 and IL-4 Expression in CD4+ T cells SA Wetzel, J Reed The Journal of Immunology 196 (1_Supplement), 55.11-55.11, 2016 | 1 | 2016 |
| Versatile tissue‐injectable hydrogels capable of the extended hydrolytic release of bioactive protein therapeutics ES Nealy, SJ Reed, SM Adelmund, BA Badeau, JA Shadish, EJ Girard, ... Bioengineering & Translational Medicine, e10668, 2024 | | 2024 |
| Versatile Tissue-Injectable Hydrogels with Extended Hydrolytic Release of Bioactive Protein Therapeutics ES Nealy, SJ Reed, SM Adelmund, BA Badeau, JA Shadish, EJ Girard, ... bioRxiv, 2023 | | 2023 |
| Therapeutic CAR T cells differentiate into diverse memory and exhausted T cell subsets in vivo to provide long-term protection from relapse and metastasis of solid tumors. SJ Reed, SJ Tower, A Khanna, V Kalia, S Sarkar The Journal of Immunology 210 (1_Supplement), 172.25-172.25, 2023 | | 2023 |
| Incorporation of pro-memory transcription factors in fourth generation CARs enhances CAR T cell immunotherapy against solid tumors in an immunocompetent murine model SJ Reed, SJ Tower, R Toumi, V Kalia, S Sarkar Cancer Research 82 (12_Supplement), 5580-5580, 2022 | | 2022 |
| Early heterogeneity of IL2R□ expression influences the programming of exhausted CD8T cells during chronic infection R Toumi, H Xiao, R Deo, SJ Reed, S Sarkar, V Kalia The Journal of Immunology 208 (1_Supplement), 182.30-182.30, 2022 | | 2022 |
| Incorporation of Id3 enhances CAR T cell therapeutic efficacy against solid tumors in an immunocompetent murine model SJ Reed, SJ Tower, M Dunga, R Toumi, V Kalia, S Sarkar The Journal of Immunology 208 (1_Supplement), 117.09-117.09, 2022 | | 2022 |
